-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2019 to Q1 2025.
- C4 Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$33.3M, a 83.7% decline year-over-year.
- C4 Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$65.2M, a 39% increase from 2023.
- C4 Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$107M, a 0.85% decline from 2022.
- C4 Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$106M, a 21.8% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)